PI
GSK icon

PEAK6 Investments’s GSK GSK Stock Holding History

PEAK6 Investments’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,800
Closed -$77.2K – 3877
2024
Q1 		$77.2K Sell
1,800
-5,000
-74% -$206K ﹤0.01% 3460
2023
Q4 		$252K Hold
6,800
– – ﹤0.01% 3088
2023
Q3 		$247K Buy
+6,800
New +$241K ﹤0.01% 2930
2023
Q2 		– Sell
-65,500
Closed -$2.33M – 4207
2023
Q1 		$2.33M Sell
65,500
-243,000
-79% -$8.5M 0.01% 1184
2022
Q4 		$10.8M Sell
308,500
-130,300
-30% -$4.34M 0.06% 342
2022
Q3 		$12.9M Buy
+438,800
New +$16.6M 0.05% 358
2022
Q2 		– Sell
-50,800
Closed -$2.77M – 6259
2022
Q1 		$2.77M Buy
+50,800
New +$2.76M 0.01% 1571
2021
Q1 		– Sell
-42,720
Closed -$1.97M – 5105
2020
Q4 		$1.97M Hold
42,720
– – ﹤0.01% 1864
2020
Q3 		$2.01M Buy
42,720
+42,480
+17,700% +$2.13M 0.01% 1662
2020
Q2 		$12K Buy
+240
New +$12.3K ﹤0.01% 4214
2020
Q1 		– Sell
-100,160
Closed -$5.88M – 4215
2019
Q4 		$5.88M Sell
100,160
-15,760
-14% -$877K 0.03% 555
2019
Q3 		$6.18M Buy
115,920
+22,880
+25% +$1.18M 0.04% 576
2019
Q2 		$4.65M Sell
93,040
-1,920
-2% -$96.3K 0.03% 747
2019
Q1 		$4.96M Sell
94,960
-110,080
-54% -$5.5M 0.03% 719
2018
Q4 		$9.79M Sell
205,040
-8,240
-4% -$406K 0.06% 346
2018
Q3 		$10.7M Buy
+213,280
New +$10.8M 0.05% 433

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

PEAK6 Investments's GSK Position: Q1 2024 in Review

PEAK6 Investments sold out of GSK (GSK) in Q1 2024, closing a stake of 1,206 shares — an estimated $49.7K sold.

PEAK6 Investments first reported a position in GSK in Q4 2018 and held it in 7 quarters. The position peaked at $7.29M in Q3 2022. 910 funds tracked by Wall St. Rank hold GSK as of Q1 2024.

  • PEAK6 Investments reported no remaining GSK position as of Q1 2024 after selling out during the quarter.
  • PEAK6 Investments sold 1,206 GSK shares in Q1 2024, an estimated $49.7K.
  • PEAK6 Investments first reported a position in GSK in Q4 2018 and held it in 7 quarters.
  • PEAK6 Investments's GSK position peaked at $7.29M in Q3 2022.
  • 910 funds tracked by Wall St. Rank held GSK as of Q1 2024.

Based on PEAK6 Investments's 13F filing for Q1 2024, filed 14 May 2024.